Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Orange is a multi-faceted pharmaceutical agent classified as a Non-Standardized Food and Plant Allergenic Extract, also exhibiting Estrogen Receptor Agonist activity. It is primarily utilized in allergen immunotherapy and specialized hormonal modulation under strict clinical supervision.
Name
Orange
Raw Name
ORANGE
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
5
Variant Count
5
Last Verified
February 17, 2026
About Orange
Orange is a multi-faceted pharmaceutical agent classified as a Non-Standardized Food and Plant Allergenic Extract, also exhibiting Estrogen Receptor Agonist activity. It is primarily utilized in allergen immunotherapy and specialized hormonal modulation under strict clinical supervision.
Detailed information about Orange
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Orange.
Orange, in a clinical and pharmacological context, refers to a complex biological extract derived from the Citrus sinensis plant. It is classified by the FDA as a Non-Standardized Food Allergenic Extract [EPC] and a Non-Standardized Plant Allergenic Extract [EPC]. Beyond its traditional use in allergy diagnostics and immunotherapy, this specific pharmacological preparation is also recognized for its activity as an Estrogen Receptor Agonist [MoA] and its classification as an Endoglycosidase [EPC]. This dual-nature makes Orange a unique agent in the pharmacological landscape, bridging the gap between immunology and endocrinology.
As an allergenic extract, Orange contains a variety of proteins, including Cit s 1 (a germin-like protein), Cit s 2 (profilin), and Cit s 3 (a lipid transfer protein). These proteins are the primary drivers of the immunological response in sensitive individuals. When used therapeutically, Orange belongs to a class of drugs called allergen immunotherapy agents. The goal of these treatments is to induce desensitization or clinical tolerance in patients who suffer from Type I hypersensitivities (IgE-mediated allergies).
Historically, the FDA has overseen the production of allergenic extracts since the early 20th century. While many extracts remain 'non-standardized'—meaning they are not compared against a national reference standard for potency—they are produced under strict Good Manufacturing Practices (GMP) to ensure consistency in protein concentration and biological activity. Healthcare providers typically use these extracts for skin prick testing (SPT) to confirm allergies or as part of a subcutaneous immunotherapy (SCIT) regimen.
The mechanism of action for Orange is bifurcated based on its clinical application.
In the context of immunotherapy, Orange works by modulating the patient's immune system over time. When administered in small, escalating doses, the extract shifts the immune response from a Th2-dominated profile (which promotes IgE production and allergic inflammation) to a Th1-dominated profile. This shift increases the production of regulatory T cells (Tregs) and the secretion of IL-10 and TGF-beta. Furthermore, it induces the production of 'blocking antibodies' known as IgG4. These antibodies compete with IgE for binding sites on the Orange allergens, effectively preventing the degranulation of mast cells and basophils when the patient is naturally exposed to the allergen.
As an Estrogen Receptor Agonist, Orange contains bioactive compounds—primarily flavonoids like hesperidin and naringenin—that possess a molecular structure capable of binding to Estrogen Receptor alpha (ERα) and Estrogen Receptor beta (ERβ). At the molecular level, these compounds mimic the action of endogenous estradiol, though typically with significantly lower potency. Upon binding, they induce a conformational change in the receptor, allowing it to translocate to the nucleus, bind to estrogen response elements (EREs) on DNA, and modulate the transcription of target genes. This activity is particularly relevant in the study of bone density, cardiovascular health, and menopausal symptom management, where weak estrogenic signals can provide therapeutic benefits without the high risks associated with potent synthetic estrogens.
Orange is FDA-approved for the following indications:
Orange is available in several specialized dosage forms:
> Important: Only your healthcare provider can determine if Orange is right for your specific condition. The use of allergenic extracts carries a risk of severe systemic reactions and must be performed in a clinical setting equipped for emergency resuscitation.
Dosage for Orange must be highly individualized based on the patient's sensitivity level and the specific clinical indication.
Orange allergenic extracts are approved for use in children, typically aged 5 years and older.
No specific dose adjustments are provided in the manufacturer labeling for renal impairment regarding the allergenic proteins. However, for oral formulations with high flavonoid content, caution is advised in patients with Stage 4 or 5 chronic kidney disease due to reduced excretion of metabolites.
Patients with severe hepatic impairment (Child-Pugh Class C) should be monitored closely, as the metabolism of the estrogenic components of Orange may be significantly delayed, potentially leading to increased systemic levels.
In patients over 65, healthcare providers typically evaluate cardiovascular health before starting Orange immunotherapy. The risk of adverse reactions to epinephrine (the primary treatment for anaphylaxis) is higher in this population, necessitating a more cautious dose escalation.
If you miss an immunotherapy appointment, do not attempt to 'double up' the next dose. If the delay is significant (e.g., more than 2 weeks past the scheduled date), your doctor may need to reduce the dose for the next injection to ensure safety. For oral supplements, skip the missed dose and return to your regular schedule.
An overdose of Orange allergenic extract usually manifests as a severe systemic allergic reaction. Signs include:
Emergency Action: If an overdose is suspected, especially via injection, epinephrine must be administered immediately, and emergency medical services (911) must be contacted.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop therapy without medical guidance, as this can lead to a loss of desensitization or increased risk of reactions.
Most patients receiving Orange extracts for immunotherapy will experience local reactions. These are typically mild and self-limiting:
> Warning: Stop taking Orange and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis:
Prolonged use of Orange as an estrogenic agent requires monitoring. Potential long-term effects include:
Orange allergenic extracts can cause severe, life-threatening systemic allergic reactions, including anaphylaxis. Because of this risk, Orange immunotherapy should only be administered in a healthcare setting by personnel trained in the management of anaphylaxis. Patients must be observed for at least 30 minutes after each injection. Patients with unstable or severe asthma are at increased risk for fatal reactions. Healthcare providers must prescribe an autoinjectable epinephrine (e.g., EpiPen) for patients receiving Orange immunotherapy and ensure they are trained in its use.
Report any unusual symptoms to your healthcare provider immediately. Even a mild reaction today could precede a severe reaction tomorrow.
Orange is a potent biological agent that requires careful clinical management. It is not a standard 'vitamin' or 'food supplement' when used in its concentrated extract form. Patients must be fully aware of the risks of systemic allergic reactions and the implications of its estrogenic activity.
Summary of FDA Black Box Warning: Orange allergenic extract is associated with a risk of anaphylaxis. It must be administered under the supervision of a physician who is prepared to treat life-threatening reactions. Patients with severe, poorly controlled asthma should not receive Orange immunotherapy as they are at the highest risk for mortality. Always remain in the clinic for the mandatory 30-minute observation period.
Orange does not typically cause sedation. However, if you experience a systemic reaction or receive epinephrine, you should not drive or operate machinery until fully recovered and cleared by a physician.
Alcohol should be avoided on the day of an Orange injection. Alcohol can increase peripheral vasodilation, which may accelerate the absorption of the allergen and increase the risk or severity of a systemic reaction.
Do not stop Orange immunotherapy abruptly without consulting your allergist. Stopping treatment for several weeks and then restarting at the previous dose can be extremely dangerous. A 'step-down' in dose is usually required if therapy is interrupted.
> Important: Discuss all your medical conditions, especially respiratory and hormonal issues, with your healthcare provider before starting Orange.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication review is essential for safety.
Orange must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a specialist:
Patients allergic to Orange may show cross-reactivity with other members of the Rutaceae family (Lemon, Lime, Grapefruit). There is also a known 'Pollen-Food Allergy Syndrome' where individuals allergic to Grass Pollen or Birch Pollen may react to Orange proteins due to structural similarities in profilin proteins.
> Important: Your healthcare provider will evaluate your complete medical history and perform a physical exam before prescribing Orange.
Pregnancy Category C: Animal reproduction studies have not been conducted with Orange allergenic extracts.
It is not known whether the allergenic proteins or the specific estrogenic metabolites of Orange are excreted in human milk. Because many proteins and flavonoids are naturally present in the diet, the risk is generally considered low. However, the decision to continue Orange immunotherapy while breastfeeding should be made after discussing the risk of a systemic reaction in the mother with a healthcare provider.
Orange is approved for use in children, typically those 5 years of age and older.
Patients over 65 years of age may be at increased risk for adverse outcomes if they experience a systemic reaction.
While the allergenic proteins are not cleared renally in a way that impacts dosing, the flavonoid metabolites are. In patients with significant renal dysfunction, the half-life of these metabolites may be extended. No specific GFR-based adjustments are currently standardized, but clinical monitoring for increased estrogenic effects is recommended.
In patients with cirrhosis or other forms of hepatic impairment, the glucuronidation of Orange flavonoids may be impaired. This could theoretically lead to higher systemic concentrations of estrogenic compounds. Use with caution in Child-Pugh Class B and C patients.
> Important: Special populations require individualized medical assessment and often more frequent monitoring than the general population.
Orange functions as a complex biological modifier. Its pharmacological activity is derived from two distinct components:
| Parameter | Value |
|---|---|
| Bioavailability | 15-25% (Oral Flavonoids) |
| Protein Binding | 80-95% (Metabolites) |
| Half-life | 6-12 hours (Flavonoids) |
| Tmax | 1-2 hours (Oral) |
| Metabolism | Hepatic (CYP3A4) and Gut Microflora |
| Excretion | Renal (70%), Fecal (30%) |
Orange is categorized as a Non-Standardized Allergenic Extract and a Phytoestrogenic agent. It is related to other citrus extracts and is part of the broader class of allergen immunotherapy biologics.
Common questions about Orange
Orange is primarily used in two clinical capacities: as a diagnostic tool for identifying citrus allergies and as a therapeutic agent for allergen immunotherapy. In immunotherapy, it is administered in gradually increasing doses to help the immune system build a tolerance to orange proteins, thereby reducing allergic symptoms like rhinitis or asthma. Additionally, due to its properties as an Estrogen Receptor Agonist, it is sometimes used in research or as a supplement to provide weak estrogenic support for bone and cardiovascular health. It is classified as a non-standardized extract, meaning its potency is determined by the manufacturer's internal standards rather than a national reference. Always use this agent under the strict supervision of an allergist or qualified healthcare provider.
The most frequent side effects associated with Orange extracts, particularly when given as an injection, are local reactions at the site of administration. These include redness, itching, and swelling (a wheal) that typically appear within minutes and resolve within a day. Some patients may also experience systemic symptoms such as increased nasal congestion, fatigue, or a mild headache shortly after treatment. If taken orally in high concentrations, mild digestive upset or breast tenderness (due to its estrogenic activity) may occur. While most side effects are mild, the risk of a severe reaction always exists. It is crucial to report any reaction larger than a few centimeters to your doctor.
It is strongly advised to avoid alcohol consumption on the days you receive an Orange immunotherapy injection. Alcohol acts as a vasodilator, which means it widens your blood vessels and increases blood flow throughout the body. This physiological change can cause the Orange extract to be absorbed more rapidly into your systemic circulation, significantly increasing the risk of a severe allergic reaction or anaphylaxis. Furthermore, alcohol can mask the early warning signs of an allergic reaction, such as feeling flushed or lightheaded. To ensure maximum safety, wait at least 24 hours after your injection before consuming alcohol. Always discuss your lifestyle habits with your healthcare provider.
The safety of Orange extracts during pregnancy is complex and requires a personalized medical consultation. Generally, healthcare providers do not recommend starting Orange immunotherapy while pregnant because of the risk of anaphylaxis, which can deprive the fetus of oxygen. However, if a woman is already on a stable maintenance dose and has shown good tolerance, many allergists will allow her to continue the treatment at that same dose. The dose is typically not increased during pregnancy to minimize the risk of a new reaction. There is no evidence that the extract itself causes birth defects, but the systemic safety of the mother is the primary concern. Always inform your allergist immediately if you become pregnant.
Orange immunotherapy is not an immediate fix for allergies; it is a long-term disease-modifying treatment. Most patients begin to notice a reduction in their allergic symptoms during the 'maintenance phase,' which usually occurs 6 to 12 months after starting the build-up injections. Significant clinical improvement typically requires at least one full year of consistent treatment. For the best long-term results, a full course of 3 to 5 years is generally recommended by the American Academy of Allergy, Asthma & Immunology. If no improvement is seen after 12 to 18 months of maintenance therapy, your doctor may re-evaluate the treatment plan. Patience and consistency are key to the success of this pharmacological intervention.
Stopping Orange immunotherapy suddenly can be done safely in terms of immediate withdrawal symptoms, as it is not an addictive substance. However, doing so will result in a gradual loss of the allergic tolerance you have built up, and your allergy symptoms will likely return to their previous severity. The most significant danger occurs if you stop for several weeks and then try to restart at your previous high dose; this can trigger a life-threatening allergic reaction because your immune system's 'memory' of the tolerance has faded. If you need to interrupt your treatment, you must consult your doctor. They will provide a 'step-down' protocol to safely re-introduce the extract at a lower dose when you are ready to resume.
If you miss a scheduled Orange immunotherapy injection, contact your allergist's office as soon as possible to reschedule. Do not attempt to take an extra dose or increase your next dose to make up for the missed one. The safety of the next injection depends on the length of time that has passed since your last dose. If only a few days have passed, you may be able to continue with your scheduled dose. However, if several weeks have passed, your doctor will likely need to reduce the dose for your next visit to prevent a reaction. For oral supplements, simply skip the missed dose and take the next one at your regularly scheduled time.
There is currently no strong clinical evidence suggesting that Orange allergenic extracts cause weight gain when used for immunotherapy. Because the treatment involves very small amounts of protein and is administered via injection, it does not have a significant caloric or metabolic impact. However, because Orange also acts as an Estrogen Receptor Agonist, some individuals might theoretically experience minor fluid retention, which can be mistaken for weight gain. This is similar to the mild bloating some women experience during their menstrual cycle. If you notice significant or rapid weight changes while taking Orange, you should discuss this with your healthcare provider to rule out other underlying causes.
Orange can interact with several types of medications, some of which are very serious. The most critical interaction is with beta-blockers, which are used for blood pressure and heart conditions; these can make an allergic reaction much harder to treat. Other drugs like ACE inhibitors and MAOIs also carry risks. If you are taking antihistamines, they may mask the early symptoms of an injection reaction, which can be dangerous. Additionally, because of its estrogenic properties, Orange may interact with hormone replacement therapy or certain cancer medications. You must provide your healthcare provider with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are using.
The concept of 'generic' is slightly different for allergenic extracts like Orange compared to synthetic pills. Because Orange is a biological product derived from natural sources and is 'non-standardized,' there is no single 'brand name' version that other companies copy. Instead, multiple biological laboratories (such as ALK, Greer, or HollisterStier) produce their own versions of Orange extract. While these extracts all contain the same primary citrus proteins, they are not considered identical or interchangeable in the same way generic ibuprofen is for Advil. If you switch manufacturers, your doctor may need to re-test your sensitivity or adjust your dose to ensure safety and efficacy.